Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of gabapentin on idiopathic tinnitus
IRCT20200127046283N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin in Idiopathic Tinnitus, sponsored by Zahedan University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
gabapentin
03
Conditions
Idiopathic Tinnitus
Beyond the preview
Go deeper on IRCT20200127046283N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046283N1.